[Federal Register: December 19, 2002 (Volume 67, Number 244)]

[Notices]               

[Page 77798]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr19de02-74]                         





-----------------------------------------------------------------------





DEPARTMENT OF HEALTH AND HUMAN SERVICES





Food and Drug Administration





 

Pulmonary-Allergy Drugs Advisory Committee; Cancellation





AGENCY:  Food and Drug Administration, HHS.





ACTION:  Notice.





-----------------------------------------------------------------------





SUMMARY: The Food and Drug Administration (FDA) is canceling the 

meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for 

December 20, 2002. This meeting was announced in the Federal Register 

of November 13, 2002 (67 FR 68878).





FOR FURTHER INFORMATION CONTACT: Kimberly L. Topper, Center for Drug 

Evaluation and Research (HFD-21), Food and Drug Administration, 5600 

Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 

Rockville, MD 20857, 301-827-7001, FAX 301-827-6776, or e-mail: 

topperk@cder.fda.gov, or FDA Advisory Committee Information Line, 1-

800-741-8138 (301-443-0572 in the Washington, DC area), code 12545.





    Dated: December 16, 2002.

Linda Arey Skladany,

Associate Commissioner for External Relations.

[FR Doc. 02-32157 Filed 12-17-02; 3:05 pm]



BILLING CODE 4160-01-S